Also trades as: TNONW (NASDAQ) · $vol 0M
TNON NASDAQ
Tenon Medical, Inc.
1W: +18.2%
1M: -17.2%
3M: +1230.9%
YTD: +279.9%
1Y: +203.3%
3Y: -70.2%
$3.70
-0.34 (-8.42%)
Weekly Expected Move ±69.2%
$-1
$1
$4
$6
$9
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
Income Trends
Revenue
$4M
+20.4% ▲
5Y CAGR: +146.0%
Gross Profit
$2M
+37.8% ▲
5Y CAGR: +147.2%
Operating Income
-$13M
+7.1% ▲
Net Income
-$13M
+8.2% ▲
EPS (Diluted)
$-1.70
+84.9% ▲
EBITDA
-$13M
+1.5% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $160K | $691K | $3M | $3M | $4M |
| YoY Growth | +265.1% | +331.9% | +323.7% | +11.9% | +20.4% |
| Cost of Revenue | $55K | $1M | $2M | $2M | $2M |
| Gross Profit | $105K | -$641K | $1M | $2M | $2M |
| Gross Margin | 65.6% | -92.8% | 42.4% | 52.2% | 59.8% |
| R&D Expenses | $2M | $3M | $3M | $3M | $2M |
| SG&A Expenses | $5M | $15M | $14M | $13M | $13M |
| Operating Expenses | $7M | $18M | $17M | $15M | $15M |
| Operating Income | -$6M | -$19M | -$16M | -$14M | -$13M |
| Operating Margin | -4038.1% | -2709.8% | -537.1% | -420.1% | -324.3% |
| Interest Expense | $621K | $354K | $21K | $34K | $0 |
| Income Before Tax | -$7M | -$19M | -$16M | -$14M | -$13M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$7M | -$19M | -$16M | -$14M | -$13M |
| Net Margin | -4405.0% | -2737.6% | -532.1% | -417.2% | -318.4% |
| EPS (Diluted) | $-624.38 | $-187.30 | $-68.64 | $-11.26 | $-1.70 |
| EBITDA | -$6M | -$18M | -$15M | -$13M | -$13M |
| Shares Outstanding | 11288 | 101000 | 227000 | 1M | 7M |